Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation.
Bastiaan J ViergeverDaniëlle A E RaatsVeerle GeurtsJasper MullendersTrudy N JongesMichiel S Van Der HeijdenJohan H van EsOnno W KranenburgRichard P MeijerPublished in: British journal of cancer (2023)
Therefore, urinoids can advance precision medicine in bladder cancer as a non-invasive platform for tumour pathogenesis, longitudinal drug-response monitoring, and therapy adaptation.